Citation Impact
Citing Papers
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
2005
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 Standout
Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
A Visualizable Chain‐Terminating Inhibitor of Glycosaminoglycan Biosynthesis in Developing Zebrafish
2014 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1)
2004
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Endogenous inhibitors of angiogenesis
2009
Identification of Vascular Lineage-Specific Genes by Transcriptional Profiling of Isolated Blood Vascular and Lymphatic Endothelial Cells
2003
MYC on the Path to Cancer
2012 Standout
Brain‐specific angiogenesis inhibitor 2 regulates VEGF through GABP that acts as a transcriptional repressor
2006
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
eIF4E – from translation to transformation
2004
Clinical translation of angiogenesis inhibitors
2002 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
2002
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
2001 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Yeasts encoding tumour antigens in cancer immunotherapy
2005
Wound repair and regeneration
2008 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
T1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
2003 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
2002 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Pericytes: gatekeepers in tumour cell metastasis?
2007
Towards patient‐specific tumor antigen selection for vaccination
2002
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Tumor Lymphangiogenesis
2003
Lymphangiogenesis in development and human disease
2005 StandoutNature
Thrombospondins: from structure to therapeutics
2008
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Integrins in angiogenesis: multitalented molecules in a balancing act
2003
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Heparan sulphate proteoglycans fine-tune mammalian physiology
2007 Nature
Angiogenesis in life, disease and medicine
2005 StandoutNature
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Targeting RAS signalling pathways in cancer therapy
2003 Standout
BAX and BAK mediate p53-independent suppression of tumorigenesis
2002
Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein
2001
Heterogeneity of Angiogenic Activity in a Human Liposarcoma: a Proposed Mechanism for "No Take" of Human Tumors in Mice
2001
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
1999
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pericytes and ocular diseases
2007
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Angiopoietin-1/Tie2 Signal Augments Basal Notch Signal Controlling Vascular Quiescence by Inducing Delta-Like 4 Expression through AKT-mediated Activation of β-Catenin
2011
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
2009
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
Vascular permeability, vascular hyperpermeability and angiogenesis
2008
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor
2005
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
2002
Endogenous Inhibitors of Angiogenesis
2005
Cell Migration: Integrating Signals from Front to Back
2003 StandoutScience
Angiogenesis Research: Guidelines for Translation to Clinical Application
2001
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
2005
Vascular Endothelial Cell Growth Factor Receptor 3–Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels
2005
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
The Molecular Diversity of Glycosaminoglycans Shapes Animal Development
2006
Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
2003
Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
2001
Improving Prospects for Targeting RAS
2015
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
2005
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
2002 StandoutScience
Role of angiogenesis in tumor growth and metastasis
2002 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts.
2003
Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking αvβ5 integrin
2003
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Suppression of tumor formation in lymph nodes by L-selectin–mediated natural killer cell recruitment
2005
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Angiogenesis
2006
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin.
2001
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Imaging the glycome
2008 StandoutNobel
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
2006
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
2003
Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice
2001
Wound-Healing Studies in Transgenic and Knockout Mice
2004
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Osteopontin at the Crossroads of Inflammation and Tumor Progression
2017
Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis
2004
Works of Michael Streit being referenced
Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy.
2002
Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell Carcinomas
1999
Integrin α5β1: a potent inhibitor of experimental lung metastasis
1998
Adhesion Receptors in Malignant Transformation and Dissemination of Gastrointestinal Tumors
1996
Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth
2002
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM‐CSF as adjuvant
2001
Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas
2000
An N-Terminal 80 kDa Recombinant Fragment of Human Thrombospondin-2 Inhibits Vascular Endothelial Growth Factor Induced Endothelial Cell Migration In Vitro and Tumor Growth and Angiogenesis In Vivo
2003
The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses
2001
Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
2000
Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice
2002
Angiogenesis, lymphangiogenesis, and melanoma metastasis
2003
Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors
1996
Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: An effective second-line regimen
1997
Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-β
2004
Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4
2001
The α1β1 and α2β1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis
2002
Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
1999